Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Charles Kunos
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
78 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Uc Irvine Health/chao Family Comprehensive Cancer Center
Orange, California, United States
- University of Colorado Cancer Center - Anschutz Cancer Pavilion
Aurora, Colorado, United States
- Smilow Cancer Hospital Care Center at Saint Francis
Hartford, Connecticut, United States
- the Hospital of Central Connecticut
New Britain, Connecticut, United States
- Florida Hospital Orlando
Orlando, Florida, United States
- Memorial University Medical Center
Savannah, Georgia, United States
- Saint Alphonsus Cancer Care Center-Boise
Boise, Idaho, United States
- Decatur Memorial Hospital
Decatur, Illinois, United States
- Sudarshan K Sharma Md Limted-Gynecologic Oncology
Hinsdale, Illinois, United States
- Memorial Medical Center
Springfield, Illinois, United States
- Indiana University/melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
- University of Iowa/holden Comprehensive Cancer Center
Iowa City, Iowa, United States
- Johns Hopkins University/sidney Kimmel Cancer Center
Baltimore, Maryland, United States
- Michigan Cancer Research Consortium Ccop
Ann Arbor, Michigan, United States
- Saint Joseph Mercy Hospital
Ann Arbor, Michigan, United States
- Oakwood Hospital and Medical Center
Dearborn, Michigan, United States
- Saint John Hospital and Medical Center
Detroit, Michigan, United States
- Hurley Medical Center
Flint, Michigan, United States
- Genesys Regional Medical Center
Grand Blanc, Michigan, United States
- Allegiance Health
Jackson, Michigan, United States
- Borgess Medical Center
Kalamazoo, Michigan, United States
- Bronson Methodist Hospital
Kalamazoo, Michigan, United States
- West Michigan Cancer Center
Kalamazoo, Michigan, United States
- Sparrow Hospital
Lansing, Michigan, United States
- Saint Mary Mercy Hospital
Livonia, Michigan, United States
- Saint Joseph Mercy Oakland
Pontiac, Michigan, United States
- Saint Joseph Mercy Port Huron
Port Huron, Michigan, United States
- Saint Mary'S of Michigan
Saginaw, Michigan, United States
- University of Mississippi Medical Center
Jackson, Mississippi, United States
- Cancer Research for the Ozarks Ncorp
Springfield, Missouri, United States
- Coxhealth South Hospital
Springfield, Missouri, United States
- Mercy Hospital Springfield
Springfield, Missouri, United States
- Women'S Cancer Center of Nevada
Las Vegas, Nevada, United States
- Cooper Hospital University Medical Center
Camden, New Jersey, United States
- Southwest Gynecologic Oncology Associates Inc
Albuquerque, New Mexico, United States
- University of New Mexico Cancer Center
Albuquerque, New Mexico, United States
- State University of New York Downstate Medical Center
Brooklyn, New York, United States
- North Shore University Hospital
Manhasset, New York, United States
- Long Island Jewish Medical Center
New Hyde Park, New York, United States
- North Shore-Lij Health System/center for Advanced Medicine
New Hyde Park, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2011
- Primary completion
- 31 Jan 2016
- Completion
- 31 Jan 2016
- Last update posted
- 8 Aug 2019
- Registered enrollment
- 27
- Registry id
- NCT01266447
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.